Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database
European Journal of Surgical Oncology · 2025-06 · 51 (6) · 109643
DOI: 10.1016/j.ejso.2025.109643 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Surgical Oncology, 2025-06. Verfasst von Giuseppe Catanuto und 16 weiteren Autor:innen. Beteiligte Einrichtung: Humanitas-Istituto Clinico Catanese Misterbianco, Catania, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoadjuvant Therapy, Mastectomy, Mastectomy, Segmental. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.
Themen: Onkologische Pflege
Abstract (Originalsprache)
AIMS: We investigated factors related to the type of surgery, i.e. mastectomy versus breast conserving surgery (BCS), in breast cancer (BC) patients with complete pathologic response in the breast (ypT0) after neoadjuvant therapy (NAT). METHODS: A retrospective analysis from the EUSOMA database was performed using data from 55 certified centers across 14 European countries, including ypT0 BC patients (i.e., neither invasive nor in situ residuals), treated between 2017 and 2022. Variables analyzed included year of surgery, age, number and distribution of tumor focality, extent, clinical and pathological stages, and biologic subtype. Logistic regression was used to identify predictors of surgical choice. The Kaplan-Meier method was used for comparison of local recurrence-free survival (LRFS) between surgical groups. RESULTS: Of 1416 BC patients included, 67.5 % underwent BCS and 32.5 % mastectomy. At multivariable analysis, factors increasing the likelihood of mastectomy included: more recent year of surgery [odds ratio (OR) 2.61, 95 % confidence interval (95%CI): 1.51-4.51,p = 0.001], younger age (OR: 0.96, 95%CI: 0.95-0.97,p < 0.001), multifocality (OR: 2.20, 95%CI: 1.61-3.00,p < 0.001) and multicentricity (OR: 12.66, 95%CI: 6.82-23.49,p < 0.001), advanced clinical tumor stage (OR: 14.54, 95%CI: 5.80-36.47,p < 0.001), and baseline axillary nodal involvement (OR: 1.56, 95%CI: 1.12-2.17,p = 0.009). Comparison between groups did not show a significant difference in LRFS (p = 0.389). CONCLUSION: Many BC patients undergo mastectomy despite achieving complete response of primary tumor after NAT. Patients-related and tumor-related features, as well as having surgery in more recent years, seems to influence this choice. Our findings suggest the need for an optimized decision-making to spare unnecessary mastectomies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Humanitas-Istituto Clinico Catanese Misterbianco, Catania, Italy.
- Breast Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
- Humanitas-Istituto Clinico Catanese Misterbianco, Catania, Italy; Department of Clinical and Experimental Medicine, University of Catania, Italy. Electronic address: federica.martorana@unict.it.
- European Society of Breast Cancer Specialists (EUSOMA), Florence, Italy.
- European Society of Breast Cancer Specialists (EUSOMA), Florence, Italy; CPO Piemonte, Turin, Italy.
- Radiation Oncology Section, Department of Medicine and Surgery, University of Perugia, Italy; Perugia General Hospital Sant'Andrea delle Fratte Perugia, Italy.
Förderung
- Pfizer
Zitieren
APA
Catanuto, G., Gentile, D., Martorana, F., Tomatis, M., Ponti, A., Marotti, L., Aristei, C., Cardoso, M. J., Cheung, K. L., Curigliano, G., De Vries, J., Karakatsanis, A., Santini, D., Sardanelli, F., Van Dam, P., Rubio, I. T., & EUSOMA Working Group (2025). Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database. European Journal of Surgical Oncology, 51(6), 109643. https://doi.org/10.1016/j.ejso.2025.109643
Vancouver
Catanuto G, Gentile D, Martorana F, Tomatis M, Ponti A, Marotti L, et al. Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database. European Journal of Surgical Oncology. 2025;51(6):109643. doi:10.1016/j.ejso.2025.109643
BibTeX
@article{Catanuto2025,
author = {Catanuto, Giuseppe and Gentile, Damiano and Martorana, Federica and Tomatis, Mariano and Ponti, Antonio and Marotti, Lorenza and Aristei, Cynthia and Cardoso, Maria Joao and Cheung, Kwok Leung and Curigliano, Giuseppe and De Vries, Jakob and Karakatsanis, Andreas and Santini, Donatella and Sardanelli, Francesco and Van Dam, Peter and Rubio, Isabel T and EUSOMA Working Group, EUSOMA Working Group},
title = {Clinico-pathological features predicting indication to mastectomy in breast cancer patients achieving complete response after neoadjuvant therapy: A retrospective analysis of the EUSOMA database},
journal = {European Journal of Surgical Oncology},
year = {2025},
volume = {51},
number = {6},
pages = {109643},
doi = {10.1016/j.ejso.2025.109643}
}
EUVIMED